{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T04:57:38Z","timestamp":1784609858368,"version":"3.55.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.prp.2022.154077","type":"journal-article","created":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T11:18:04Z","timestamp":1660389484000},"page":"154077","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["miR-574, miR-499, miR-125b, miR-106a, and miR-9 potentially target TGFBR-1 and TGFBR-2 genes involving in inflammatory response pathway: Potential novel biomarkers for chronic lymphocytic leukemia"],"prefix":"10.1016","volume":"238","author":[{"given":"Nasrin","family":"Hadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faezeh","family":"Namazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Ketabchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farinaz","family":"Khosravian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behnaz","family":"Nateghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Talebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Baghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamidreza","family":"Mianesaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fateme","family":"Zare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansoor","family":"Salehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2022.154077_bib1","doi-asserted-by":"crossref","unstructured":"H.M. Parry, T. Stevens, C. Oldreive, B. Zadran, T. McSkeane, Z. Rudzki, S. Paneesha, C. Chadwick, T. Stankovic, G.J.O. Pratt, NK cell function is markedly impaired in patients with chronic lymphocytic leukaemia but is preserved in patients with small lymphocytic lymphoma. 7 (2016) 68513.","DOI":"10.18632\/oncotarget.12097"},{"key":"10.1016\/j.prp.2022.154077_bib2","doi-asserted-by":"crossref","unstructured":"F. Koohi, R. Shamlou, S. Eslami, Z.M. Ghojogh, Y. Kor, H.J.A.P.Jo.C.P. Rafiemanesh, Leukemia in Iran: epidemiology and morphology trends. 16 (2015) 7759\u20137763.","DOI":"10.7314\/APJCP.2015.16.17.7759"},{"key":"10.1016\/j.prp.2022.154077_bib3","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1182\/blood.V87.12.4990.bloodjournal87124990","article-title":"National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment","volume":"87","author":"Cheson","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.prp.2022.154077_bib4","doi-asserted-by":"crossref","unstructured":"S.-l Hayashi, J.M. Gimble, A. Henley, L.R. Ellingsworth, P.W. Kincade, Differential effects of TGF-beta 1 on lymphohemopoiesis in long-term bone marrow cultures. (1989).","DOI":"10.1182\/blood.V74.5.1711.bloodjournal7451711"},{"key":"10.1016\/j.prp.2022.154077_bib5","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/sj.leu.2401384","article-title":"The TGF-\u03b2 type II receptor in chronic myeloid leukemia: analysis of microsatellite regions and gene expression","volume":"13","author":"Rooke","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.prp.2022.154077_bib6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3109\/10428199509051712","article-title":"Comparative analysis of cytokines released by bone marrow stromal cells from normal donors and B-cell chronic lymphocytic leukemic patients","volume":"17","author":"Lagneaux","year":"1995","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.prp.2022.154077_bib7","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1046\/j.1365-2141.1997.792715.x","article-title":"Heterogenous response of B lymphocytes to transforming growth factor\u2010beta in B\u2010cell chronic lymphocytic leukaemia: correlation with the expression of TGF\u2010\u03b2 receptors","volume":"97","author":"Lagneaux","year":"1997","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.prp.2022.154077_bib8","first-page":"346","article-title":"Identification of a Global Gene Expression Signature of B-Chronic Lymphocytic Leukemia1 1 Mayo Comprehensive Cancer Center, National Cancer Institute CA91542 (awarded to NE Kay), and generous philanthropic support provided by Edson Spencer","volume":"1","author":"Jelinek","year":"2003","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.prp.2022.154077_bib9","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1084\/jem.194.11.1625","article-title":"Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells","volume":"194","author":"Klein","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.prp.2022.154077_bib10","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/1476-4598-9-306","article-title":"Serum microRNAs as non-invasive biomarkers for cancer","volume":"9","author":"Brase","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.prp.2022.154077_bib11","first-page":"362","article-title":"Identification of key candidate genes and miRNA\u2011mRNA target pairs in chronic lymphocytic leukemia by integrated bioinformatics analysis","volume":"19","author":"Gao","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.prp.2022.154077_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-015-0185-1","article-title":"MicroRNA (miRNA) in cancer","volume":"15","author":"Reddy","year":"2015","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.prp.2022.154077_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-019-1599-9","article-title":"MicroRNA-181a-5p and microRNA-181a-3p cooperatively restrict vascular inflammation and atherosclerosis","volume":"10","author":"Su","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.prp.2022.154077_bib14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.prp.2022.154077_bib15","first-page":"1","article-title":"Global similarity method based on a two-tier random walk for the prediction of microRNA\u2013disease association","volume":"8","author":"Chen","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2022.154077_bib16","doi-asserted-by":"crossref","first-page":"E1052","DOI":"10.1002\/humu.21141","article-title":"Evaluation of SNPs in miR\u2010146a, miR196a2 and miR\u2010499 as low\u2010penetrance alleles in German and Italian familial breast cancer cases","volume":"31","author":"Catucci","year":"2010","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.prp.2022.154077_bib17","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/gutjnl-2011-301083","article-title":"miR-574-5p negatively regulates Qki6\/7 to impact \u03b2-catenin\/Wnt signalling and the development of colorectal cancer","volume":"62","author":"Ji","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.prp.2022.154077_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-4598-7-35","article-title":"Potential role of miR-9 and miR-223 in recurrent ovarian cancer","volume":"7","author":"Laios","year":"2008","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.prp.2022.154077_bib19","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1515\/CCLM.2011.708","article-title":"Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers","volume":"49","author":"Vinci","year":"2011","journal-title":"Clin. Chem. Lab. Med. (CCLM)"},{"key":"10.1016\/j.prp.2022.154077_bib20","first-page":"D845","article-title":"The DisGeNET knowledge platform for disease genomics: 2019 update","volume":"48","author":"Pi\u00f1ero","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.prp.2022.154077_bib21","first-page":"D498","article-title":"The reactome pathway knowledgebase","volume":"48","author":"Jassal","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.prp.2022.154077_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/npre.2007.1311.1","article-title":"The NCI-Nature Pathway Interaction Database: A cell signaling resource","author":"Krupa","year":"2007","journal-title":"Nat. Preced."},{"key":"10.1016\/j.prp.2022.154077_bib23","doi-asserted-by":"crossref","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","article-title":"KEGG: new perspectives on genomes, pathways, diseases and drugs","volume":"45","author":"Kanehisa","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.prp.2022.154077_bib24","doi-asserted-by":"crossref","first-page":"W165","DOI":"10.1093\/nar\/gkt430","article-title":"miRmap web: comprehensive microRNA target prediction online","volume":"41","author":"Vejnar","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.prp.2022.154077_bib25","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.05005","article-title":"Predicting effective microRNA target sites in mammalian mRNAs","volume":"4","author":"Agarwal","year":"2015","journal-title":"elife"},{"key":"10.1016\/j.prp.2022.154077_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206239","article-title":"miRWalk: An online resource for prediction of microRNA binding sites","volume":"13","author":"Sticht","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.prp.2022.154077_bib27","doi-asserted-by":"crossref","first-page":"D1013","DOI":"10.1093\/nar\/gky1010","article-title":"HMDD v3. 0: a database for experimentally supported human microRNA\u2013disease associations","volume":"47","author":"Huang","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.prp.2022.154077_bib28","doi-asserted-by":"crossref","first-page":"W460","DOI":"10.1093\/nar\/gkv403","article-title":"DIANA-miRPath v3. 0: deciphering microRNA function with experimental support","volume":"43","author":"Vlachos","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.prp.2022.154077_bib29","doi-asserted-by":"crossref","first-page":"11755","DOI":"10.1073\/pnas.0404432101","article-title":"MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias","volume":"101","author":"Calin","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.prp.2022.154077_bib30","doi-asserted-by":"crossref","first-page":"15524","DOI":"10.1073\/pnas.242606799","article-title":"Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia","volume":"99","author":"Calin","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.prp.2022.154077_bib31","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/gcc.20580","article-title":"Deregulated expression of miR\u2010106a predicts survival in human colon cancer patients","volume":"47","author":"D\u00edaz","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.prp.2022.154077_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2019.111734","article-title":"MiR-106a-5p modulates apoptosis and metabonomics changes by TGF-\u03b2\/Smad signaling pathway in cleft palate","volume":"386","author":"Zhang","year":"2020","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.prp.2022.154077_bib33","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.biopha.2017.10.062","article-title":"MicroRNA-574-5p promotes cell growth of vascular smooth muscle cells in the progression of coronary artery disease","volume":"97","author":"Lai","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.prp.2022.154077_bib34","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/JTO.0b013e318208c785","article-title":"miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer","volume":"6","author":"Foss","year":"2011","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.prp.2022.154077_bib35","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.gene.2016.12.032","article-title":"Upregulation of microRNA-574-3p in a human gastric cancer cell line AGS by TGF-\u03b21","volume":"605","author":"Zhang","year":"2017","journal-title":"Gene"},{"key":"10.1016\/j.prp.2022.154077_bib36","first-page":"303","article-title":"Circulating miR-499 are novel and sensitive biomarker of acute myocardial infarction","volume":"7","author":"Zhang","year":"2015","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.prp.2022.154077_bib37","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/jid.2011.55","article-title":"MiR-125b, a microRNA downregulated in psoriasis, modulates keratinocyte proliferation by targeting FGFR2","volume":"131","author":"Xu","year":"2011","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.prp.2022.154077_bib38","doi-asserted-by":"crossref","first-page":"13111","DOI":"10.1073\/pnas.1006151107","article-title":"miRNA malfunction causes spinal motor neuron disease","volume":"107","author":"Haramati","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.prp.2022.154077_bib39","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1159\/000484303","article-title":"Epigenetically-regulated microRNA-9-5p suppresses the activation of hepatic stellate cells via TGFBR1 and TGFBR2","volume":"43","author":"Yu","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.prp.2022.154077_bib40","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1080\/21645515.2017.1327107","article-title":"Transforming growth factor-\u03b2: A therapeutic target for cancer","volume":"13","author":"Haque","year":"2017","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.prp.2022.154077_bib41","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022277","article-title":"TGF-\u03b2 family signaling in tumor suppression and cancer progression","volume":"9","author":"Seoane","year":"2017","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.prp.2022.154077_bib42","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.trecan.2016.11.008","article-title":"Targeting TGF-\u03b2 signaling in cancer","volume":"3","author":"Colak","year":"2017","journal-title":"Trends Cancer"},{"key":"10.1016\/j.prp.2022.154077_bib43","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM200005043421807","article-title":"Role of transforming growth factor \u03b2 in human disease","volume":"342","author":"Blobe","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.prp.2022.154077_bib44","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.3324\/haematol.12402","article-title":"The effect of FK506 on transforming growth factor \u03b2 signaling and apoptosis in chronic lymphocytic leukemia B cells","volume":"93","author":"Romano","year":"2008","journal-title":"Haematologica"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033822003211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033822003211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:53:32Z","timestamp":1759733612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033822003211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":44,"alternative-id":["S0344033822003211"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2022.154077","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"miR-574, miR-499, miR-125b, miR-106a, and miR-9 potentially target TGFBR-1 and TGFBR-2 genes involving in inflammatory response pathway: Potential novel biomarkers for chronic lymphocytic leukemia","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2022.154077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154077"}}